BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33483585)

  • 1. The expression of YWHAZ and NDRG1 predicts aggressive outcome in human prostate cancer.
    Lage-Vickers S; Bizzotto J; Valacco MP; Sanchis P; Nemirovsky S; Labanca E; Scorticati C; Mazza O; Mitrofanova A; Navone N; Vazquez E; Cotignola J; Gueron G
    Commun Biol; 2021 Jan; 4(1):103. PubMed ID: 33483585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia.
    Kawahara R; Recuero S; Nogueira FCS; Domont GB; Leite KRM; Srougi M; Thaysen-Andersen M; Palmisano G
    Proteomics; 2019 Nov; 19(21-22):e1900174. PubMed ID: 31576646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CIP2A expression in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue mıcroarray study.
    Celikden SG; Baspinar S; Ozturk SA; Karaibrahimoglu A
    Malays J Pathol; 2020 Aug; 42(2):227-236. PubMed ID: 32860375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.
    Zeng L; Rowland RG; Lele SM; Kyprianou N
    Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered N-myc downstream-regulated gene 1 protein expression in African-American compared with caucasian prostate cancer patients.
    Caruso RP; Levinson B; Melamed J; Wieczorek R; Taneja S; Polsky D; Chang C; Zeleniuch-Jacquotte A; Salnikow K; Yee H; Costa M; Osman I
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):222-7. PubMed ID: 14734473
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Kim YH; Byun YJ; Kim WT; Jeong P; Yan C; Kang HW; Kim YJ; Lee SC; Moon SK; Choi YH; Yun SJ; Kim WJ
    J Korean Med Sci; 2018 Nov; 33(47):e303. PubMed ID: 30450027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and significance of PCNA and p27 in benign prostate hypertrophy and prostate carcinoma].
    Lai JS; Xia Q; Zhang XB; Zhao GP; Xu SL; Zheng DS
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):476-8. PubMed ID: 15555337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics-based signature for human benign prostate hyperplasia and prostate adenocarcinoma.
    Alaiya AA; Al-Mohanna M; Aslam M; Shinwari Z; Al-Mansouri L; Al-Rodayan M; Al-Eid M; Ahmad I; Hanash K; Tulbah A; Bin Mahfooz A; Adra C
    Int J Oncol; 2011 Apr; 38(4):1047-57. PubMed ID: 21305254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implication of miRNA-153 on PTEN expression in prostatic adenocarcinoma.
    Aboushousha T; El-Nahas EI; El-Hindawi A; Elwi D; El-Ganzouri H; Hammam O; Magdy M; Helal NS
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):6834-6843. PubMed ID: 34859846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of PARP-1 and its active polymer PAR in prostate cancer and benign prostatic hyperplasia in Chinese patients.
    Wu W; Zhu H; Liang Y; Kong Z; Duan X; Li S; Zhao Z; Yang D; Zeng G
    Int Urol Nephrol; 2014 Jul; 46(7):1345-9. PubMed ID: 24436031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
    Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
    Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-expression of TLR-9 and MMP-13 is associated with the degree of tumour differentiation in prostate cancer.
    Kalantari E; Abolhasani M; Roudi R; Farajollahi MM; Farhad S; Madjd Z; Askarian-Amiri S; Mohsenzadegan M
    Int J Exp Pathol; 2019 Apr; 100(2):123-132. PubMed ID: 31090157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic copy number alterations by whole-exome sequencing implicates YWHAZ and PTK2 in castration-resistant prostate cancer.
    Menon R; Deng M; Rüenauver K; Queisser A; Peifer M; Pfeifer M; Offermann A; Boehm D; Vogel W; Scheble V; Fend F; Kristiansen G; Wernert N; Oberbeckmann N; Biskup S; Rubin MA; Adler D; Perner S
    J Pathol; 2013 Dec; 231(4):505-16. PubMed ID: 24114522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prostate cancer immunome: In silico functional analysis of antigenic proteins from microarray profiling with IgG.
    Luna-Coronell JA; Vierlinger K; Gamperl M; Hofbauer J; Berger I; Weinhäusel A
    Proteomics; 2016 Apr; 16(8):1204-14. PubMed ID: 27089054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
    Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
    J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metastasis suppressor NDRG1 directly regulates androgen receptor signaling in prostate cancer.
    Lim SC; Geleta B; Maleki S; Richardson DR; Kovačević Ž
    J Biol Chem; 2021 Dec; 297(6):101414. PubMed ID: 34785213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of YWHAZ expression in localized prostate cancer.
    Rüenauver K; Menon R; Svensson MA; Carlsson J; Vogel W; Andrén O; Nowak M; Perner S
    Prostate Cancer Prostatic Dis; 2014 Dec; 17(4):310-4. PubMed ID: 25156059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of N-myc downstream regulated gene 1 caused by the methylation of CpG islands of NDRG1 promoter promotes proliferation and invasion of prostate cancer cells.
    Li Y; Pan P; Qiao P; Liu R
    Int J Oncol; 2015 Sep; 47(3):1001-8. PubMed ID: 26202882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin.
    Song Y; Oda Y; Hori M; Kuroiwa K; Ono M; Hosoi F; Basaki Y; Tokunaga S; Kuwano M; Naito S; Tsuneyoshi M
    Hum Pathol; 2010 Feb; 41(2):214-22. PubMed ID: 19800102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ghrelin receptor as a novel imaging target for prostatic neoplasms.
    Lu C; McFarland MS; Nesbitt RL; Williams AK; Chan S; Gomez-Lemus J; Autran-Gomez AM; Al-Zahrani A; Chin JL; Izawa JI; Luyt LG; Lewis JD
    Prostate; 2012 Jun; 72(8):825-33. PubMed ID: 21919027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.